Table: Hisamitsu -2022/23 group results

Hisamitsu Pharmaceutical Co

13/04/2023 07:00

Apr 13 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 28, 2023    Feb 28, 2022   Feb 29, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            128.33          120.19         132.30                 
                 (+6.8 pct)      (+5.0 pct)     (+3.1 pct)               
  Operating         11.60            9.34          11.80                 
                 (+24.2 pct)     (-12.5 pct)    (+1.7 pct)               
  Recurring         16.05           12.64          14.60                 
                 (+27.0 pct)     (+6.8 pct)     (-9.0 pct)               
  Net
  Net               11.74            9.66          10.60                 
                 (+21.6 pct)     (+4.4 pct)     (-9.7 pct)               
  EPS            148.01 yen      118.92 yen     133.60 yen               
  EPS Diluted    147.88 yen      118.84 yen                              
  Ann Div         84.50 yen       84.00 yen      85.00 yen               
  -Q2 Div         42.25 yen       42.00 yen      42.50 yen               
  -Q4 Div         42.25 yen       42.00 yen      42.50 yen               
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T